Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1331

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 1331
---
10) 
     1,141,710 

    Alexander Rosén 
    2024  
     77,000  

     26,655(11) 
     103,655 
  
    Chief Administration Officer 
    2023(12) 

     218,855  
     255,248  

     27,259(13) 
     501,362 

    Alison Silva 
    2024  
     96,250  

     42,294(14) 
     138,544 
  
    Chief Business Officer and President 
    2023(15) 
     -  
     -  
     146,602  
     363,481  

     35,000(16) 
     545,083 

(1)Amounts
                                            reflect the aggregate grant-date fair value of stock awards computed in accordance with the
                                            Financial Accounting Standards Board’s Accounting Standards Codification Topic 718.
                                            See Note 6 – Stockholders’ Equity (Deficit) – Stock Options.

(2)Includes
                                            healthcare benefits and 401(k) contribution of $19,326 and $0, respectively, for the fiscal
                                            year ended December 31, 2024.

(3)During
                                            2023, Mr. Rosén agreed to defer all salary compensation and to reduce his salary to
                                            $84,000 beginning on October 1, 2023. The deferred compensation is recorded in accrued compensation
                                            as of December 31, 2023. No interest was accrued or due on the deferred compensation for
                                            2023.

On
September 29, 2023, Mr. Rosén agreed to forgive $1,433,938 of earned compensation in exchange for 710,344 options to purchase
common stock, 430,181 restricted stock units, and $179,242 to be paid out as a bonus upon an IPO. The options to purchase common stock
have a strike price of $1.33. On December 18, 2023, the restricted stock units issued on September 29, 2023 were cancelled and reissued
as part of an additional forgiveness, whereby Mr. Rosén agreed to forgive the $179,242 of accrued bonus in exchange for 88,909
options to purchase common stock and an additional 67,215 restricted stock units (total of 497